Literature DB >> 2473312

Effect of endothelin-1 on regional vascular resistances in the pig.

J Pernow1, A Franco-Cereceda, R Matran, J M Lundberg.   

Abstract

The actions of endothelin-1 (ET-1) on vascular resistances were investigated and characterized in anesthetized pigs in vivo. Intravenously administered ET-1 (2-400 pmol/kg) caused dose-dependent increases in mean arterial blood pressure accompanied by a reduction in heart rate. ET-1 also increased renal, coronary, femoral, and bronchial vascular resistances. The kidney was about 10 times more sensitive to ET-1 than the other regions. The ET-1-induced vasoconstriction in the kidney was attenuated by nifedipine (100 micrograms/kg). The responses to ET-1 in the femoral and bronchial vascular beds were biphasic with an initial decrease followed by an increase in vascular resistance at high doses. It is concluded that ET-1 causes dose-dependent vasoconstriction in several vascular beds in vivo with the most pronounced effects in the renal circulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473312     DOI: 10.1097/00005344-198900135-00058

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

1.  Identification of two nuclear factor of activated T-cells (NFAT)-response elements in the 5'-upstream regulatory region of the ET-1 promoter.

Authors:  Kevin A Strait; Peter K Stricklett; Rachel M Kohan; Donald E Kohan
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

Review 2.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Functional heterogeneity of NADPH oxidase-mediated contractions to endothelin with vascular aging.

Authors:  Matthias R Meyer; Matthias Barton; Eric R Prossnitz
Journal:  Life Sci       Date:  2013-12-29       Impact factor: 5.037

Review 5.  Endothelin-1 and the kidney--beyond BP.

Authors:  Neeraj Dhaun; David J Webb; David C Kluth
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

6.  Endothelin and endothelium-derived relaxing factor control of basal renovascular tone in hydronephrotic rat kidneys.

Authors:  E Gulbins; J Hoffend; A P Zou; M S Dietrich; K Schlottmann; A Cavarape; M Steinhausen
Journal:  J Physiol       Date:  1993-09       Impact factor: 5.182

7.  Involvement of the metabolic sensor GPR81 in cardiovascular control.

Authors:  Kristina Wallenius; Pia Thalén; Jan-Arne Björkman; Petra Johannesson; John Wiseman; Gerhard Böttcher; Ola Fjellström; Nicholas D Oakes
Journal:  JCI Insight       Date:  2017-10-05

Review 8.  The Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease.

Authors:  Rupesh Raina; Abigail Chauvin; Ronith Chakraborty; Nikhil Nair; Haikoo Shah; Vinod Krishnappa; Kirsten Kusumi
Journal:  Kidney Dis (Basel)       Date:  2019-12-18

9.  Comparison of vascular and respiratory effects of endothelin-1 in the pig.

Authors:  M G Clement; M Dimori; M Albertini
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

Review 10.  Endothelin Blockade in Diabetic Kidney Disease.

Authors:  Lidia Anguiano; Marta Riera; Julio Pascual; María José Soler
Journal:  J Clin Med       Date:  2015-05-25       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.